futibatinib
Showing 1 - 7 of 7
Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)
Not yet recruiting
- Locally Advanced Unresectable or Metastatic Esophageal Cancer
- Futibatinib
- +6 more
- (no location specified)
Jul 6, 2023
Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Hepatocellular Carcinoma
- +4 more
- Futibatinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma Trial in Houston (Futibatinib, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- Futibatinib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus
Recruiting
- Metastatic Breast Cancer
- +2 more
- Futibatinib
- Futibatinib plus Fulvestrant
-
Phoenix, Arizona
- +36 more
Jan 27, 2023
Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)
Active, not recruiting
- Advanced or Metastatic Solid Tumor
- +2 more
- Futibatinib
-
Gilbert, Arizona
- +60 more
Oct 20, 2022
Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)
Not yet recruiting
- Biliary Tract Neoplasms
- Futibatinib
- +9 more
-
Brussels, Belgium
- +56 more
Nov 7, 2022
Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in
Active, not recruiting
- Cholangiocarcinoma
- +5 more
- Futibatinib
-
Gilbert, Arizona
- +57 more
Jan 5, 2022